{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:42:42Z","timestamp":1763415762989,"version":"build-2065373602"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cvsm.2025.03.008","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:18:33Z","timestamp":1747293513000},"page":"559-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complications of Liver Disease"],"prefix":"10.1016","volume":"55","author":[{"given":"Jonathan A.","family":"Lidbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2025.03.008_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1040638713520602","article-title":"Total serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis","volume":"26","author":"Gomez","year":"2014","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.cvsm.2025.03.008_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jvim.15467","article-title":"ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs","volume":"33","author":"Webster","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/jvim.16413","article-title":"Gastroduodenal ulceration in dogs with liver disease","volume":"36","author":"O'Kell","year":"2022","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib4","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jvim.15630","article-title":"Clinical, clinicopathologic, and gastrointestinal changes from administration of clopidogrel, prednisone, or combination in healthy dogs: a double-blind randomized trial","volume":"33","author":"Whittemore","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib5","first-page":"428","article-title":"Portal hypertensive gastropathy","volume":"3","author":"Wong","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/liv.14054","article-title":"Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States","volume":"39","author":"Shaheen","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cvsm.2025.03.008_bib7","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.3748\/wjg.v30.i43.4602","article-title":"Comprehensive approach to esophageal variceal bleeding: from prevention to treatment","volume":"30","author":"Singh","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1740-8261.2009.01616.x","article-title":"Acquired portal collateral circulation in the dog and cat","volume":"51","author":"Bertolini","year":"2010","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.cvsm.2025.03.008_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jvim.16355","article-title":"Esophageal varices in dogs: a retrospective case series","volume":"36","author":"Slead","year":"2022","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cvsm.2009.02.007","article-title":"Important clinical syndromes associated with liver disease","volume":"39","author":"Rothuizen","year":"2009","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/vr.100627","article-title":"Serum gastrin concentrations in dogs with liver disorders","volume":"171","author":"Mazaki-Tovi","year":"2012","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2025.03.008_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2460\/javma.244.1.78","article-title":"Endovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001-2011)","volume":"244","author":"Weisse","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2025.03.008_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jsap.12788","article-title":"Intrahepatic congenital portosystemic shunts in dogs: short- and long-term outcome of suture attenuation","volume":"59","author":"Tivers","year":"2018","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1939-1676.2010.0651.x","article-title":"Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs","volume":"25","author":"Tolbert","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jvim.15337","article-title":"ACVIM consensus statement: support for rational administration of gastrointestinal protectants to dogs and cats","volume":"32","author":"Marks","year":"2018","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.23315","article-title":"Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial","volume":"51","author":"Everhart","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cvsm.2025.03.008_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2460\/javma.1988.193.09.1109","article-title":"Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977-1985)","volume":"193","author":"Strombeck","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2025.03.008_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-5827.1991.tb00844.x","article-title":"Breed, sex and age distribution in dogs with chronic liver disease: a demographic study","volume":"32","author":"Andersson","year":"1991","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/apt.12044","article-title":"Review article: the reversibility of cirrhosis","volume":"36","author":"Sohrabpour","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2025.03.008_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","article-title":"Hepatic fibrosis: molecular mechanisms and drug targets","volume":"45","author":"Lotersztajn","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib22","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.cvsm.2025.03.008_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","article-title":"Cellular sources of extracellular matrix in hepatic fibrosis","volume":"12","author":"Wells","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cvsm.2025.03.008_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s10620-010-1507-8","article-title":"The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort","volume":"56","author":"Abu Dayyeh","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cvsm.2025.03.008_bib25","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","article-title":"Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis","volume":"277","author":"Murphy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cvsm.2025.03.008_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jvim.14891","article-title":"Hepatic fibrosis in dogs","volume":"32","author":"Eulenberg","year":"2018","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cvsm.2016.11.007","article-title":"Getting the most out of liver biopsy","volume":"47","author":"Lidbury","year":"2017","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib28","doi-asserted-by":"crossref","unstructured":"van den Ingh TS, Van Winkle T, Cullen JM, et al. Morphological classification of parenchymal disorders of the canine and feline liver: hepatocellular death, hepatitis, and cirrhosis-2 (updated version). WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. Society of Comparative Hepatology; 2006. Available at: https:\/\/comparativehepatology.org\/wsava-liver-standards\/.","DOI":"10.1016\/B978-0-7020-2791-8.50011-3"},{"key":"10.1016\/j.cvsm.2025.03.008_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jvim.12520","article-title":"Histopathologic variation between liver lobes in dogs","volume":"29","author":"Kemp","year":"2015","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jvim.14684","article-title":"Interobserver agreement using histological scoring of the canine liver","volume":"31","author":"Lidbury","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tvjl.2016.02.010","article-title":"New advances in the diagnosis of canine and feline liver and pancreatic disease","volume":"215","author":"Lidbury","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2025.03.008_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/01652176.2013.826881","article-title":"A retrospective study of oral prednisolone treatment in canine chronic hepatitis","volume":"33","author":"Favier","year":"2013","journal-title":"Vet Q"},{"key":"10.1016\/j.cvsm.2025.03.008_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jvim.12002","article-title":"Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease","volume":"27","author":"Hackett","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20870","article-title":"Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes","volume":"42","author":"Sola","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cvsm.2025.03.008_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-230X-14-131","article-title":"Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C","volume":"14","author":"Flores-Contreras","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib37","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","article-title":"Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C","volume":"297","author":"Colmenero","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1939-1676.2011.00691.x","article-title":"Portal hypertension: pathophysiology, diagnosis, and treatment","volume":"25","author":"Buob","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cvsm.2025.03.008_bib40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jvim.14687","article-title":"Hepatic and plasma endothelin-1 in dogs with chronic hepatitis","volume":"31","author":"Sakamoto","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jvim.15661","article-title":"Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals","volume":"34","author":"Sakamoto","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jvim.14639","article-title":"Thromboelastography in dogs with chronic hepatopathies","volume":"31","author":"Fry","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1939-1676.2012.00893.x","article-title":"Portal vein thrombosis in 33 dogs: 1998-2011","volume":"26","author":"Respess","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/203794","article-title":"Clinical manifestations of portal hypertension","volume":"2012","author":"Al-Busafi","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cvsm.2009.02.005","article-title":"Update on hepatobiliary imaging","volume":"39","author":"Gaschen","year":"2009","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib46","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4254\/wjh.v8.i36.1602","article-title":"Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension","volume":"8","author":"Garbuzenko","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1740-8261.1980.tb00597.x","article-title":"Indirect and direct determination of the portal vein pressure in normal and abnormal dogs and normal cats","volume":"21","author":"Schmidt","year":"1980","journal-title":"Vet Radiol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib48","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/jvim.14802","article-title":"Portal vein\/aorta ratio in dogs with acquired portosystemic collaterals","volume":"31","author":"Sakamoto","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guixe-Muntet","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1939-1676.2008.0230.x","article-title":"Ascites is a negative prognostic indicator in chronic hepatitis in dogs","volume":"23","author":"Raffan","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib52","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.13750","article-title":"To salt or not to salt?-That is the question in cirrhosis","volume":"38","author":"Haberl","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cvsm.2025.03.008_bib53","series-title":"Kirk\u2019s current veterinary therapy","first-page":"591","article-title":"Ascites and hepatic encephalopathy therapy for liver disease","author":"Bexfield","year":"2014"},{"key":"10.1016\/j.cvsm.2025.03.008_bib54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cvsm.2016.11.008","article-title":"Hepatic encephalopathy","volume":"47","author":"Gow","year":"2017","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2025.03.008_bib56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cvsm.2025.03.008_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2460\/javma.247.2.176","article-title":"Putative precipitating factors for hepatic encephalopathy in dogs: 118 cases (1991-2014)","volume":"247","author":"Lidbury","year":"2015","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2025.03.008_bib58","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0016-5085(79)80112-2","article-title":"GI production of ammonia","volume":"77","author":"Weber","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cvsm.2025.03.008_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(85)80063-5","article-title":"Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle","volume":"1","author":"Haussinger","year":"1985","journal-title":"J Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib60","first-page":"R859","article-title":"Renal regulation of interorgan glutamine flow in metabolic acidosis","volume":"251","author":"Welbourne","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0026-0495(76)90075-5","article-title":"Muscle nitrogen metabolism in chronic hepatic insufficiency","volume":"25","author":"Ganda","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/j.cvsm.2025.03.008_bib62","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.4142\/jvs.2020.21.e44","article-title":"Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting","volume":"21","author":"Williams","year":"2020","journal-title":"J Vet Sci"},{"key":"10.1016\/j.cvsm.2025.03.008_bib63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1152\/physrev.1987.67.2.440","article-title":"Biochemistry and physiology of brain ammonia","volume":"67","author":"Cooper","year":"1987","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cvsm.2025.03.008_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.10.32","article-title":"Pathogenesis and diagnosis of hepatic encephalopathy","volume":"4","author":"McPhail","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082303","article-title":"Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts","volume":"9","author":"Tivers","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cvsm.2025.03.008_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11011-012-9278-x","article-title":"Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS","volume":"27","author":"Gow","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cvsm.2025.03.008_bib67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1939-1676.2009.0408.x","article-title":"Whole blood manganese concentrations in dogs with congenital portosystemic shunts","volume":"24","author":"Gow","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/vec.12473","article-title":"Hepatic encephalopathy in dogs and cats","volume":"26","author":"Lidbury","year":"2016","journal-title":"J Vet Emerg Crit Care"},{"key":"10.1016\/j.cvsm.2025.03.008_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0034-5288(18)32352-X","article-title":"Arterial and venous ammonia concentrations in the diagnosis of canine hepato-encephalopathy","volume":"33","author":"Rothuizen","year":"1982","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cvsm.2025.03.008_bib70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2460\/javma.245.5.527","article-title":"Long-term survival and quality of life in dogs with clinical signs associated with a congenital portosystemic shunt after surgical or medical treatment","volume":"245","author":"Greenhalgh","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2025.03.008_bib71","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/vms3.1171","article-title":"Outcomes in dogs with congenital extrahepatic portosystemic shunts treated with surgical ligation or medical management","volume":"9","author":"Beardall","year":"2023","journal-title":"Vet Med Sci"},{"key":"10.1016\/j.cvsm.2025.03.008_bib72","series-title":"Small animal critical care medicine","first-page":"438","article-title":"Hepatic encephalopathy","author":"Holt","year":"2009"},{"key":"10.1016\/j.cvsm.2025.03.008_bib73","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1939-1676.2009.0327.x","article-title":"Soy protein isolate versus meat-based low-protein diet for dogs with congenital portosystemic shunts","volume":"23","author":"Proot","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MEG.0b013e3283417567","article-title":"Hepatic encephalopathy: from pathophysiology to therapeutic management","volume":"23","author":"Bismuth","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bmj.323.7306.233","article-title":"Neomycin should not be used to treat hepatic encephalopathy","volume":"323","author":"Curioso","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.cvsm.2025.03.008_bib76","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/jvim.16464","article-title":"Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts","volume":"36","author":"Serrano","year":"2022","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cvsm.2016.11.009","article-title":"Hemostatic disorders associated with hepatobiliary disease","volume":"47","author":"Webster","year":"2017","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib78","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cvsm.2025.03.008_bib79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5152\/dir.2018.17525","article-title":"Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review","volume":"25","author":"Midia","year":"2019","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cvsm.2004.10.002","article-title":"Feline hepatic lipidosis","volume":"35","author":"Center","year":"2005","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2025.03.008_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrgastro.2014.121","article-title":"Procoagulant therapeutics in liver disease: a critique and clinical rationale","volume":"11","author":"Shah","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib82","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1572-0241.2003.07467.x","article-title":"Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study","volume":"98","author":"Youssef","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib83","first-page":"173","article-title":"Effects of potassium adsorption filters on the removal of ammonia from blood products","volume":"16","author":"Fujita","year":"2018","journal-title":"Blood Transfus"},{"key":"10.1016\/j.cvsm.2025.03.008_bib84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2460\/javma.24.03.0216","article-title":"Tranexamic acid stops hyperfibrinolysis in dogs with hemorrhagic shock: a randomized, controlled clinical trial","volume":"263","author":"Mays","year":"2025","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2025.03.008_bib85","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2460\/ajvr.77.11.1258","article-title":"Effect of aminocaproic acid on clot strength and clot lysis of canine blood determined by use of an in vitro model of hyperfibrinolysis","volume":"77","author":"Brown","year":"2016","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2025.03.008_bib86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1939-1676.2008.0048.x","article-title":"Portal vein thrombosis in cats: 6 cases (2001-2006)","volume":"22","author":"Rogers","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.blre.2014.10.002","article-title":"Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?","volume":"29","author":"Hugenholtz","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.cvsm.2025.03.008_bib88","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jvim.13441","article-title":"Thromboelastographic evaluation of dogs with acute liver disease","volume":"29","author":"Kelley","year":"2015","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2025.03.008_bib89","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/vco.12924","article-title":"Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: a Veterinary Society of Surgical Oncology prospective study","volume":"21","author":"Fontes","year":"2023","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.cvsm.2025.03.008_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1098612X20939828","article-title":"Thromboelastography in cats with cholestatic liver disease","volume":"23","author":"Kakar","year":"2021","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.cvsm.2025.03.008_bib91","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1939-1676.2000.tb01169.x","article-title":"Proteins invoked by vitamin K absence and clotting times in clinically ill cats","volume":"14","author":"Center","year":"2000","journal-title":"J Vet Intern Med"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561625000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561625000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:22:57Z","timestamp":1762262577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561625000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0195561625000440"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2025.03.008","relation":{},"ISSN":["0195-5616"],"issn-type":[{"type":"print","value":"0195-5616"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2025.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}